On Invalid Date, Evolent Health (NYSE: EVH) reported Q4 2023 earnings per share (EPS) of -$0.37, up 236.36% year over year. Total Evolent Health earnings for the quarter were -$41.40 million. In the same quarter last year, Evolent Health's earnings per share (EPS) was -$0.11.
As of Q2 2024, Evolent Health's earnings has grown year over year. Evolent Health's earnings in the past year totalled -$142.26 million.
What is EVH's earnings date?
Evolent Health's earnings date is Invalid Date. Add EVH to your watchlist to be reminded of EVH's next earnings announcement.
What was EVH's revenue last quarter?
On Invalid Date, Evolent Health (NYSE: EVH) reported Q4 2023 revenue of $556.06 million up 45.4% year over year. In the same quarter last year, Evolent Health's revenue was $382.43 million.
What was EVH's revenue growth in the past year?
As of Q2 2024, Evolent Health's revenue has grown 45.26% year over year. This is 33.14 percentage points higher than the US Health Information Services industry revenue growth rate of 12.11%. Evolent Health's revenue in the past year totalled $1.96 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.